fk 633 has been researched along with Anesthesia in 1 studies
*Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanemitsu, S; Nishikawa, M; Onoda, K; Shiku, H; Shimono, T; Shimpo, H; Tanaka, K; Yada, I; Yazaki, A | 1 |
1 other study(ies) available for fk 633 and Anesthesia
| Article | Year |
|---|---|
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
Topics: Abciximab; Alprostadil; Anesthesia; Annexin A5; Antibodies, Monoclonal; Anticoagulants; Arginine; Blood Platelets; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Dual Specificity Phosphatase 2; Extracorporeal Circulation; Heparin; Humans; Immunoglobulin Fab Fragments; P-Selectin; Pipecolic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Sulfonamides; Treatment Outcome; von Willebrand Factor | 2003 |